Castle Biosciences, a diagnostics company specializing in tests for dermatologic and gastroenterological diseases, announced its executive management will present a company overview at the Piper Sandler 38th Annual Healthcare Conference on December 2, 2026. The presentation will be available via live audio webcast on the company's website, with a replay following the live event. This event provides an opportunity for investors and stakeholders to learn about the company's latest developments and strategic direction in personalized diagnostic testing.
Castle Biosciences' upcoming presentation at the Piper Sandler Healthcare Conference is noted here alongside Pluang's health sector snapshot as of Nov 12, 2026 04:11 WIB. Among 150 health-sector US stocks on Pluang, 87 rose and 61 fell today. Erasca Inc. (ERAS) gained 8.72% to USD 16.83 with a typical hold time of 4 days, contrasting with BioNano Genomics Inc. (BNGO) which dropped 10.57% to USD 1.10 and had a more balanced buy/sell order activity. Hims and Hers Health Inc. (HIMS) rose 8.68% to USD 20.79 despite 82% of orders being sell-side, held typically for 24 days.
The global beverage market is projected to grow from $2.03 trillion in 2026 to $2.78 trillion by 2032, at a CAGR of 5.35%. Growth is fueled by rising demand for nonalcoholic and functional beverages, convenience packaging, and premium products for sp...
DelveInsight's 2026 report reveals more than 200 GLP-1 receptor agonists and incretin-based therapies are in development by over 180 companies, targeting conditions like type 2 diabetes, obesity, and related metabolic disorders. Key players such as E...
Vylor, Inc. announced its Q3 2026 financial results showing a slight decline in net sales and increased losses compared to last year, mainly due to volume decreases from weather and market shifts. Despite this, the company saw strong demand for its h...
Octave Intelligence plc has acquired Cerebre, a U.S.-based software firm that creates connected plant models by integrating engineering schematics and plant data. This acquisition aims to strengthen Octave's industrial AI capabilities, especially for...
Cardinal Health's Board of Directors has approved a quarterly dividend of $0.5158 per share, to be paid on January 15, 2027. This dividend will be distributed from the company's capital surplus to shareholders recorded by January 4, 2027. Cardinal He...
